Oral & Topical Anaesthetics Market
Oral & Topical Anaesthetics Market Size, Trend Analysis & Competition Tracking By Drug class type (Non-aqueous, Aqueous), By Route of Administration (Gels, Ointments, Solutions, Adhesive patch), By Distribution Channel (Hospitals, Dental Clinics, Pharmacies and drug stores, E-commerce) - Global Market Insights 2018 to 2028
Analysis of Oral & Topical Anaesthetics Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Overview
Anesthesia is reversible loss sensation which is induces by a drug known as anesthetics. Amongst these drugs, Oral & Topical anesthetics are the drugs that reversibly block nerve conduction in and around the target site of administration, mainly in mouth or oral sites. Oral & Topical Anesthetics penetrate mucosal surfaces of mouth more easily than through a keratinized surface because of the absence of a stratum corneum (through the openings of the hair follicles and sweat glands.
Oral & Topical anesthetics are being widely used in anesthesia, dentistry, and aesthetic surgery as they cause superficial loss of pain sensation after direct application. Local Oral & Topical Anesthetics remains major healthcare tool for pain control in anesthesia, oral and dentistry. However, research and development are still undergoing to seek new products in Oral & Topical Anesthetics market for managing the pain. Most of the Oral & Topical Anesthetics researches are focused on improvement in the area of anesthetic agents and route of administration such as gels, ointments, solutions and adhesive patches.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Oral & Topical Anaesthetics Market: Drivers and Restraints
Global Oral & Topical Anesthetics market is primarily driven by the increase in the incidences of dental associated problems and diseases. Some other driving factors in the Oral & Topical Anesthetics market include increase awareness amongst population about oral care, government healthcare initiatives and training programs, increase in dental patients, and oral cosmetic surgeries. Moreover, increase in the number of anesthesiologists and dentists globally, will also propel the growth of Oral & Topical Anesthetics market.
However, stringent regulatory guidelines for drug approval, availability of skilled anesthesiologists and dentist, and side effects of anesthetic drugs may affect the growth of the global Oral & Topical Anesthetics market. In addition, poor healthcare infrastructure in low economic countries will impede growth Oral & Topical Anesthetics market over the forecast period.
Oral & Topical Anaesthetics Market: Overview
Globally, Oral & Topical Anesthetics market will witness growth due to many factors which includes emergence of new drug products in oral tropical care, increase in dental patients, rise and awareness in disposable income in developing nations, demand oral care, and need for improved and less painful anesthetic administration.
According to The Lancet Commission on Global Health 2015, around 5 billion people worldwide lack access to surgical and an aesthetic care, most of these are in lower income countries. Therefore leading drug manufacturers are focused to provide new and innovative generic Oral & Topical Anesthetics drugs which will not only improve the painless treatment but also incur low medical costs. Furthermore, entering of new players into Oral & Topical Anesthetics is also expected to create a healthy competitive environment in the global Oral & Topical Anesthetics market during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Oral & Topical Anaesthetics Market: Regional Outlook
Region-wise, the global Oral & Topical Anesthetics market is classified into regions namely North America, Latin America, Europe, CIS & Russia, Japan, Asia Pacific Excluding Japan, ASEAN Countries, Middle East and Africa. North America is will lead the Oral & Topical Anesthetics market due to high healthcare investments, presence major pharmaceutical research hubs and high standard of living. The European Oral & Topical Anesthetics market will be the second largest market and will flourish thanks to the increasing number of medical professionals and growing awareness.
The steady increase in the number of dentists and anesthesiologist in Europe specifically in Germany, France, U.K and Italy will propel the market growth of Oral & Topical Anesthetics Market in the region. Asia Pacific will be the fastest growing Oral & Topical Anesthetics market as it comprises of large and small healthcare entities which provides scope for healthy competition and growth opportunity. Latin America Oral & Topical Anesthetics market is expected to hold the fifth largest market share after Asia Pacific due to increasing trend towards competitive environment amongst drug manufacturers and medical awareness among the population.
Japan, being a developed economy will have the major contribution in Oral & Topical Anesthetics market. However, CIS & Russia will have moderate growth in Oral & Topical Anesthetics Market due to average customer base. The Middle East and Africa will hold the lowest share of Oral & Topical Anesthetics market, owing to average medical facilities, poor political environment in Africa and low funding.
Oral & Topical Anaesthetics Market: Key Players
Some of the key players operating in the global Oral & Topical Anesthetics anesthesia market are
- Astra Zeneca (UK)
- Septodont (US)
- Dentsply (US)
- Sirona (US)
- GlaxoSmithKline PLC (US)
- Gilead Sciences Inc. (US)
- Johnson & Johnson (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Baxter International Inc. (US)
- Abbott Laboratories (US)
- Hospira, Inc. (US)
- Hikma Pharmaceuticals PLC (UK)
- AbbVie Inc. (US)
- Fresenius Se & Co. Kgaa (Germany)
- Others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
- Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
- Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Oral & Topical Anaesthetics Market: Segmentation
Tentatively, the global Oral & Topical Anesthetics market can be segmented on the basis of drug class type, route of administration and duration of action.
-
Based on drug class type, the global Oral & Topical Anesthetics market is segmented as:
- Non-aqueous
- Ethyl aminobenzoate (benzocaine)
- Lidocaine base
- Eutectic mixture of lidocaine and prilocaine
- Aqueous
- Benzyl alcohol
- Tetracaine hydrochloride
- Lidocaine hydrochloride
- Non-aqueous
-
Based on Route of Administration, the global Oral & Topical Anesthetics market is segmented as:
- Gels
- Ointments
- Solutions
- Adhesive patch
-
Based on duration of action, the global Oral & Topical Anesthetics market is segmented as:
- Short
- Medium
- Long
-
Based on Distribution Channel, the global Oral & Topical Anesthetics market is segmented as:
- Hospitals
- Dental Clinics
- Pharmacies and drug stores
- E-commerce
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Drug Class Type
- 6.2. Route Of Administration
- 6.3. Duration Of Action
- 6.4. Distribution Channel
- 7. Global Market Analysis and Forecast, By Drug Class Type
- 7.1. Non-aqueous
- 7.2. Aqueous
- 8. Global Market Analysis and Forecast, By Route Of Administration
- 8.1. Gels
- 8.2. Ointments
- 8.3. Solutions
- 8.4. Adhesive Patch
- 9. Global Market Analysis and Forecast, By Duration Of Action
- 9.1. Short
- 9.2. Medium
- 9.3. Long
- 10. Global Market Analysis and Forecast, By Distribution Channel
- 10.1. Hospitals
- 10.2. Dental Clinics
- 10.3. Pharmacies and Drug Stores
- 10.4. E-commerce
- 11. Global Market Analysis and Forecast, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. Asia Pacific
- 11.6. East Asia
- 11.7. MEA
- 12. North America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 18. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 19. Sales Forecast by Drug Class Type, Route Of Administration, Duration Of Action, and Distribution Channel for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Astra Zeneca (UK)
- 21.2. Septodont (US)
- 21.3. Dentsply (US)
- 21.4. Sirona (US)
- 21.5. GlaxoSmithKline PLC (US)
- 21.6. Gilead Sciences Inc. (US)
- 21.7. Johnson & Johnson (US)
- 21.8. F. Hoffmann-La Roche Ltd. (Switzerland)
- 21.9. Baxter International Inc. (US)
- 21.10. Abbott Laboratories (US)
- 21.11. Hospira, Inc. (US)
- 21.12. Hikma Pharmaceuticals PLC (UK)
- 21.13. AbbVie Inc. (US)
- 21.14. Fresenius Se & Co. Kgaa (Germany)
- 21.15. Others
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Drug Class Type
Table 3: Global Market US$ Mn Forecast by Route Of Administration
Table 4: Global Market US$ Mn Forecast by Duration Of Action
Table 5: Global Market US$ Mn Forecast by Distribution Channel
Table 6: North America Market US$ Mn Forecast by Country
Table 7: North America Market US$ Mn Forecast by Drug Class Type
Table 8: North America Market US$ Mn Forecast by Route Of Administration
Table 9: North America Market US$ Mn Forecast by Duration Of Action
Table 10: North America Market US$ Mn Forecast by Distribution Channel
Table 11: Latin America Market US$ Mn Forecast by Country
Table 12: Latin America Market US$ Mn Forecast by Drug Class Type
Table 13: Latin America Market US$ Mn Forecast by Route Of Administration
Table 14: Latin America Market US$ Mn Forecast by Duration Of Action
Table 15: Latin America Market US$ Mn Forecast by Distribution Channel
Table 16: Western Europe Market US$ Mn Forecast by Country
Table 17: Western Europe Market US$ Mn Forecast by Drug Class Type
Table 18: Western Europe Market US$ Mn Forecast by Route Of Administration
Table 19: Western Europe Market US$ Mn Forecast by Duration Of Action
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 21: Eastern Europe Market US$ Mn Forecast by Country
Table 22: Eastern Europe Market US$ Mn Forecast by Drug Class Type
Table 23: Eastern Europe Market US$ Mn Forecast by Route Of Administration
Table 24: Eastern Europe Market US$ Mn Forecast by Duration Of Action
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 26: Asia Pacific Market US$ Mn Forecast by Country
Table 27: Asia Pacific Market US$ Mn Forecast by Drug Class Type
Table 28: Asia Pacific Market US$ Mn Forecast by Route Of Administration
Table 29: Asia Pacific Market US$ Mn Forecast by Duration Of Action
Table 30: Asia Pacific Market US$ Mn Forecast by Distribution Channel
Table 31: East Asia Market US$ Mn Forecast by Country
Table 32: East Asia Market US$ Mn Forecast by Drug Class Type
Table 33: East Asia Market US$ Mn Forecast by Route Of Administration
Table 34: East Asia Market US$ Mn Forecast by Duration Of Action
Table 35: East Asia Market US$ Mn Forecast by Distribution Channel
Table 36: MEA Market US$ Mn Forecast by Country
Table 37: MEA Market US$ Mn Forecast by Drug Class Type
Table 38: MEA Market US$ Mn Forecast by Route Of Administration
Table 39: MEA Market US$ Mn Forecast by Duration Of Action
Table 40: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 26: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 27: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 28: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 29: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 30: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 31: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 32: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 33: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 34: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 35: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What will be the demand outlook for oral & topical anaesthetics market?
The oral & topical anaesthetics market is expected to garner a market value of US$ 841 Million by the end of 2028.
Which region will spearhead the growth in oral & topical anaesthetics market?
Europe is expected to possess 39% market share for oral & topical anaesthetics market in the forecast period 2018-2028.
What is the anticipated growth of the oral & topical anaesthetics market until 2028?
The oral & topical anaesthetics market is expected to register a CAGR of 5% in the forecast period 2018-2028.
Oral & Topical Anaesthetics Market